Fmoc-Azetidine-3-carboxylic acid

Fmoc-Azetidine-3-carboxylic acid is an Fmoc-protected azetidine-3-carboxylic acid bearing a four-membered cyclic amine and a stereogenic center at the azetidine ring position, depending on the supplied stereochemical form. The molecule combines an N-(9H-fluoren-9-ylmethoxycarbonyl) protecting group with a carboxylic acid functionality, creating a peptide-compatible building block that can be activated for amide bond formation while remaining stable under base conditions used in Fmoc chemistry. The constrained azetidine ring introduces distinct steric and conformational properties that can influence peptide backbone geometry, receptor binding motifs, and protease susceptibility in downstream analogs. The presence of the free carboxyl group enables controlled coupling and subsequent transformations into amides, esters, or other functional derivatives for synthetic and biochemical workflows.

1. Peptide Synthesis

Fmoc-Azetidine-3-carboxylic acid supports solid-phase and solution-phase peptide coupling workflows where Fmoc removal and subsequent amide formation are required. The Fmoc-protected ring nitrogen and the carboxylic acid allow orthogonal handling: Fmoc deprotection can expose the amine for stepwise chain assembly while the azetidine framework remains intact as a conformationally constrained amino acid analog. The ring strain and fixed geometry can be leveraged to construct peptide sequences containing azetidine residues that probe backbone effects on folding and binding. Downstream peptide products can be used as research-grade standards, SAR scaffolds, or peptidomimetic intermediates for continued derivatization.

2. Peptidomimetics Design

Fmoc-Azetidine-3-carboxylic acid is suitable for peptidomimetic construction where cyclic amino acid features are used to tune conformational preference and side-chain presentation. The azetidine ring functions as a rigid, stereochemically defined substituent, while the carboxyl group provides a handle for incorporation into amide-linked pharmacophore scaffolds. Fmoc protection enables iterative assembly of analog libraries, including sequences designed to modulate hydrogen-bonding patterns and steric profiles relative to canonical amino acids. Resulting azetidine-containing peptides and peptide-like molecules can serve as chemical biology probes and structure-activity relationship candidates for systematic scaffold refinement.

3. Chiral Building Block Synthesis

Fmoc-Azetidine-3-carboxylic acid serves as a chiral amino acid intermediate for stereoselective synthesis of azetidine-containing derivatives. The chiral center within the azetidine ring can be retained through Fmoc-based protection and coupling steps, enabling downstream stereochemically consistent products such as N-alkylated or C-functionalized analogs after controlled functional group transformations. The combination of an Fmoc-protected amine and a carboxylic acid supports a common protecting-group strategy: maintain the ring nitrogen masked during manipulations that target the carboxyl group or side-chain derivatization. The resulting chiral intermediates can be applied to fine chemical synthesis routes that require conformationally constrained, stereodefined building blocks.

4. Side-Chain Functionalization

Fmoc-Azetidine-3-carboxylic acid can be employed in side-chain functionalization and derivative preparation where the carboxylic acid is converted into activated intermediates for further coupling chemistry. The azetidine ring nitrogen, protected as Fmoc, can be unmasked selectively during synthesis to enable formation of additional amide linkages or to support subsequent derivatization strategies that depend on orthogonality. Carboxyl activation can also lead to ester or amide derivatives that serve as intermediates for generating labeled reagents, affinity handles, or solubility-modulating analogs. Downstream functionalized products can feed into biochemical research programs requiring defined stereochemistry and controlled attachment points.

5. Chemical Manufacturing Intermediates

Fmoc-Azetidine-3-carboxylic acid is applicable as a process chemistry intermediate for manufacturing azetidine-containing peptide building blocks and related specialty chemicals. The Fmoc group provides a robust protection scheme compatible with base-mediated deprotection cycles, supporting scalable synthesis of protected amino acid derivatives and peptide fragments under controlled conditions. The free carboxylic acid enables conversion to activated forms used in coupling operations, while the cyclic amine structure contributes a reproducible motif for consistent intermediate quality across batches. Industrial workflows can utilize the compound to prepare defined peptidomimetic intermediates, processable library members, and downstream materials that require conformationally constrained amino acid incorporation.

1. The spatiotemporal control of signalling and trafficking of the GLP-1R

2. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

4. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

5. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics